Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NBY

NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals Inc New
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:NBY
DateTimeSourceHeadlineSymbolCompany
24/01/202500:13Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
24/01/202500:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
24/01/202500:00Business WireNovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution ProposalAMEX:NBYNovaBay Pharmaceuticals Inc New
23/01/202508:27Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
11/01/202510:06Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:NBYNovaBay Pharmaceuticals Inc New
10/01/202523:03Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
19/12/202423:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
19/12/202422:50Business WireNovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of StockholdersAMEX:NBYNovaBay Pharmaceuticals Inc New
12/12/202408:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
09/12/202423:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
09/12/202422:50Business WireNovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special MeetingAMEX:NBYNovaBay Pharmaceuticals Inc New
27/11/202408:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
23/11/202408:27Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
23/11/202408:05Business WireNovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
16/11/202400:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
16/11/202400:00Business WireProminent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova BrandAMEX:NBYNovaBay Pharmaceuticals Inc New
14/11/202409:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
13/11/202408:52Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
12/11/202422:01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
09/11/202409:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
08/11/202408:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
08/11/202408:05Business WireNovaBay Pharmaceuticals Reports Third Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
07/11/202408:58Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
07/11/202408:46Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
07/11/202408:05Business WireNovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase PriceAMEX:NBYNovaBay Pharmaceuticals Inc New
29/10/202423:19Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
29/10/202423:15Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
29/10/202423:00Business WireNovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLCAMEX:NBYNovaBay Pharmaceuticals Inc New
17/10/202407:27Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
17/10/202407:19Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionAMEX:NBYNovaBay Pharmaceuticals Inc New
 Showing the most relevant articles for your search:AMEX:NBY